Loading company
Just reported
Q3 2026 results
From Envista's results release of November 4, 2026; its quarterly report has since been filed.
Revenue
Actual
$691.5M
+3.2% y/y
-5.3% q/qGuided
—
No guide given
EPS, GAAP
Actual
$3.11
Guided
—
No guide given
EPS, adjusted: $0.40
Operating income, GAAP
Actual
$515.2M
Guided
—
No guide given
Company outlook
Full year 2026
- EPS, adjusted$1.54 – $1.58Raised +2.3%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.$152.5BA+
MDLNMedline Inc.$52.6BA
ALCAlcon Inc.$35BA
BLCOBausch & Lomb Corp$7.6BA-
ATRCAtriCure, Inc.$2.9BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A
EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now A
How it makes money
- Specialty Products & Technologies65%
- Equipment & Consumables35%
Shares of revenue are estimates for six months ended July 3, 2026, not figures from a filing.
Competes with
What it sells6
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Show 3 more
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Who buys it6
- General dentists buy imaging equipment, restorative materials, instruments, and other supplies for their practices, directly or through distributors.
- Oral surgeons, periodontists, and other dental specialists buy implant systems, surgical products, and related planning tools.
- Orthodontists buy brackets, wires, clear aligners, and treatment-planning tools.
Show 3 more
- Dental service organizations (DSOs), which operate groups of dental practices, buy products across several categories for use across their practices.
- Dental laboratories buy products used to make dental restorations and other lab work.
- Third-party distributors buy Envista products for resale to dental practices; they distributed 42% of the company’s products (2025, high). Henry Schein accounted for 12% of Envista sales (2025, high).
What it stands on, and what could break it
What the business leans on
- 1Some specially specified or qualified materials, components, or services come from a single supplier or a limited number of suppliers, so interruptions could delay production.
- 2Envista relies on distributors and other channel partners to reach customers; channel partners accounted for 89% of Equipment & Consumables segment sales (2025, high).
- 3Its products are subject to medical-device and other healthcare rules in the United States and other countries, including requirements for product clearances, manufacturing quality, and post-sale reporting.
- 4Demand for some dental procedures depends on patients’ ability or willingness to pay, since many dental costs are paid out of pocket.
What could go wrong
- 1Trade duties can raise the cost of imported products and components. Envista reported tariff costs and uncertainty about the timing and recovery of some tariff refunds in its latest quarterly report.
- 2China’s volume-based procurement policies have cut prices for dental and medical consumables, which can reduce revenue from products sold into that market.
- 3Envista depends on distributors for a substantial portion of sales, and Henry Schein alone accounted for 12% of sales (2025, high); a change in that relationship or in its purchasing could affect sales.
About Envista Holdings Corporation
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
- Head office
- Brea, California
- Founded
- 2018
- Employees
- approximately 12,000 (December 31, 2025, high)
- Listed on
- NYSE
- Financial year ends
- December 31
Built from Envista Holdings Corporation’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
